WebThe management of patients with breast cancer involves surgery, radiotherapy, drug therapy, or a combination of these. The course of the disease and the therapeutic approach vary depending on the characteristics of the cancer. Factors such as patient age, menopausal status, tumour size and grade, involvement of axillary lymph nodes or skin, and ... WebSupport: 888-992-3836 Home NewsWire Subscriptions ...
Aromasin Side Effects: Common, Severe, Long Term
WebApr 12, 2024 · As aromatase inhibitors (AIs) are studied past the standard 5-year treatment duration in postmenopausal, estrogen/progesterone receptor-positive breast cancer … WebFeb 3, 2024 · Known side effects of aromatase inhibitors include an increased risk of osteoporosis, which can cause bone fractures. In the analysis, a slightly higher proportion of women in the aromatase inhibitor group had a bone fracture over the follow-up period, compared with the tamoxifen group: 6.4% vs 5.1%. chucky junior webber
Extended therapy may benefit breast cancer patients
WebThe hormones oestrogen and progesterone, particularly oestrogen, can encourage some breast cancers to grow. Hormonal therapies reduce the amount of oestrogen in the body … WebGuidelines recommended a minimum of 5 years of adjuvant therapy with an aromatase inhibitor or tamoxifen followed by an aromatase inhibitor (in either order) for such patients. 3 – 5 However, the safety and efficacy of extending treatment with an aromatase inhibitor for another 5 years are unknown. Recently, Goss et al 6 reported results from ... WebMay 27, 2024 · The main deciding factor between aromatase inhibitors may be the tolerability of the drugs regarding potential side effects. The same study found that exemestane could be an option for up-front adjuvant therapy for postmenopausal hormone receptor-positive breast cancer without the need for two to three years of tamoxifen … chucky junior death